[Instenon in a combined therapy of patients with dyscirculatory encephalopathy].
Kotov
S V
SV
Neretin
V Ia
VIa
Isakova
E V
EV
Riabtseva
A A
AA
Bystrova
E K
EK
D000368:Aged; D001549:Benzamides / Q000627:therapeutic use*; D001921:Brain / Q000098:blood supply*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000175:diagnosis / Q000628:therapy*; D003131:Combined Modality Therapy; D004338:Drug Combinations; D055590:Electromagnetic Phenomena / Q000379:methods; D005260:Female; D006592:Hexobendine / Q000627:therapeutic use*; D006801:Humans; D006931:Hyperbaric Oxygenation / Q000379:methods; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D013806:Theophylline / Q000031:analogs & derivatives* / Q000627:therapeutic use
D001549:Benzamides; D000697:Central Nervous System Stimulants; D004338:Drug Combinations; C001453:Instenon; D006592:Hexobendine; D013806:Theophylline